Contrasting Waters Corporation (WAT) and Its Peers
Waters Corporation (NYSE: WAT) is one of 82 public companies in the “Advanced Medical Equipment & Technology” industry, but how does it weigh in compared to its competitors? We will compare Waters Corporation to related businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.
This is a breakdown of recent ratings and price targets for Waters Corporation and its competitors, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Waters Corporation Competitors||417||2185||3396||123||2.53|
Waters Corporation currently has a consensus price target of $185.20, suggesting a potential upside of 2.23%. As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 21.29%. Given Waters Corporation’s higher possible upside, research analysts plainly believe Waters Corporation is more favorable than its competitors.
This table compares Waters Corporation and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Waters Corporation Competitors||-332.41%||-33.62%||-12.57%|
Earnings and Valuation
This table compares Waters Corporation and its competitors revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Waters Corporation||$2.21 billion||$766.04 million||27.37|
|Waters Corporation Competitors||$2.02 billion||$430.37 million||-69.39|
Waters Corporation has higher revenue and earnings than its competitors. Waters Corporation is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Risk & Volatility
Waters Corporation has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Waters Corporation’s competitors have a beta of 0.89, meaning that their average share price is 11% less volatile than the S&P 500.
Insider and Institutional Ownership
91.0% of Waters Corporation shares are owned by institutional investors. Comparatively, 53.1% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 5.1% of Waters Corporation shares are owned by insiders. Comparatively, 16.8% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Waters Corporation beats its competitors on 8 of the 13 factors compared.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. It also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA product line. It is also a developer and supplier of software-based products that interface with the Company’s instruments, as well as other suppliers’ instruments. Its LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a range of compounds.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.